<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35533732</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1095-8584</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>169</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>06</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of molecular and cellular cardiology</Title>
          <ISOAbbreviation>J Mol Cell Cardiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Partial and complete loss of myosin binding protein H-like cause cardiac conduction defects.</ArticleTitle>
        <Pagination>
          <StartPage>28</StartPage>
          <EndPage>40</EndPage>
          <MedlinePgn>28-40</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.yjmcc.2022.04.012</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0022-2828(22)00077-3</ELocationID>
        <Abstract>
          <AbstractText>A premature truncation of MYBPHL in humans and a loss of Mybphl in mice is associated with dilated cardiomyopathy, atrial and ventricular arrhythmias, and atrial enlargement. MYBPHL encodes myosin binding protein H-like (MyBP-HL). Prior work in mice indirectly identified Mybphl expression in the atria and in small puncta throughout the ventricle. Because of its genetic association with human and mouse cardiac conduction system disease, we evaluated the anatomical localization of MyBP-HL and the consequences of loss of MyBP-HL on conduction system function. Immunofluorescence microscopy of normal adult mouse ventricles identified MyBP-HL-positive ventricular cardiomyocytes that co-localized with the ventricular conduction system marker contactin-2 near the atrioventricular node and in a subset of Purkinje fibers. Mybphl heterozygous ventricles had a marked reduction of MyBP-HL-positive cells compared to controls. Lightsheet microscopy of normal perinatal day 5 mouse hearts showed enrichment of MyBP-HL-positive cells within and immediately adjacent to the contactin-2-positive ventricular conduction system, but this association was not apparent in Mybphl heterozygous hearts. Surface telemetry of Mybphl-null mice revealed atrioventricular block and atrial bigeminy, while intracardiac pacing revealed a shorter atrial relative refractory period and atrial tachycardia. Calcium transient analysis of isolated Mybphl-null atrial cardiomyocytes demonstrated an increased heterogeneity of calcium release and faster rates of calcium release compared to wild type controls. Super-resolution microscopy of Mybphl heterozygous and homozygous null atrial cardiomyocytes showed ryanodine receptor disorganization compared to wild type controls. Abnormal calcium release, shorter atrial refractory period, and atrial dilation seen in Mybphl null, but not wild type control hearts, agree with the observed atrial arrhythmias, bigeminy, and atrial tachycardia, whereas the proximity of MyBP-HL-positive cells with the ventricular conduction system provides insight into how a predominantly atrial expressed gene contributes to ventricular arrhythmias and ventricular dysfunction.</AbstractText>
          <CopyrightInformation>Copyright Â© 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Barefield</LastName>
            <ForeName>David Y</ForeName>
            <Initials>DY</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Genetic Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America; Department of Cell and Molecular Physiology, Loyola University Chicago, Maywood, IL, United States of America. Electronic address: dbarefield@luc.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yamakawa</LastName>
            <ForeName>Sean</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Genetic Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tahtah</LastName>
            <ForeName>Ibrahim</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Genetic Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sell</LastName>
            <ForeName>Jordan J</ForeName>
            <Initials>JJ</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Genetic Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Broman</LastName>
            <ForeName>Michael</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Cardiology, Department of Medicine, University of Chicago, Chicago, IL, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Laforest</LastName>
            <ForeName>Brigitte</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Section of Cardiology, Department of Medicine, University of Chicago, Chicago, IL, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Harris</LastName>
            <ForeName>Sloane</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Genetic Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alvarez-Arce</LastName>
            <ForeName>Alejandro</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cell and Molecular Physiology, Loyola University Chicago, Maywood, IL, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Araujo</LastName>
            <ForeName>Kelly N</ForeName>
            <Initials>KN</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cell and Molecular Physiology, Loyola University Chicago, Maywood, IL, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Puckelwartz</LastName>
            <ForeName>Megan J</ForeName>
            <Initials>MJ</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Genetic Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wasserstrom</LastName>
            <ForeName>J Andrew</ForeName>
            <Initials>JA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine and The Feinberg Cardiovascular and Renal Institute, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fishman</LastName>
            <ForeName>Glenn I</ForeName>
            <Initials>GI</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiology, NYU Grossman School of Medicine, NY, New York, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McNally</LastName>
            <ForeName>Elizabeth M</ForeName>
            <Initials>EM</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Genetic Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America. Electronic address: Elizabeth.mcnally@northwestern.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>F32 HL131304</GrantID>
            <Acronym>HL</Acronym>
            <Agency>NHLBI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>K99 HL141698</GrantID>
            <Acronym>HL</Acronym>
            <Agency>NHLBI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R00 HL141698</GrantID>
            <Acronym>HL</Acronym>
            <Agency>NHLBI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Mol Cell Cardiol</MedlineTA>
        <NlmUniqueID>0262322</NlmUniqueID>
        <ISSNLinking>0022-2828</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Atrial cardiomyocyte</Keyword>
        <Keyword MajorTopicYN="N">Cardiomyopathy</Keyword>
        <Keyword MajorTopicYN="N">MYBPHL</Keyword>
        <Keyword MajorTopicYN="N">MyBP-HL</Keyword>
        <Keyword MajorTopicYN="N">Myosin binding protein</Keyword>
        <Keyword MajorTopicYN="N">Ventricular conduction system</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>9</Day>
          <Hour>19</Hour>
          <Minute>23</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35533732</ArticleId>
        <ArticleId IdType="doi">10.1016/j.yjmcc.2022.04.012</ArticleId>
        <ArticleId IdType="pii">S0022-2828(22)00077-3</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
